Articles

At the American College of Cardiology Scientific Session, a study of prescriptions for PCSK9 inhibitors confirms what doctors say about trying to get their patients access to the cholesterol drug.

Access to PCSK9 Inhibitors Still Restricted

A double dose of inclisiran reduced LDL cholesterol up to 52.6%.

Experimental PCSK9 Inhibitor Substantially Reduces LDL Cholesterol

Discrepancies found when comparing real-world findings to clinical trial findings.

Real-World Data May Conflict with Clinical Trial Data

Preliminary trial finds moderate-intensity exercise does not increase adverse events in this patient population. 

Moderate-Intensity Training Improves Exercise Capacity in Hypertrophic Cardiomyopathy

Researchers sought to change the volume of fatty deposits in a coronary artery that was at least 30% blocked.

Synthetic Cholesterol Drug Disappoints in Trial

Study compares common treatment options to prevent recurrent venous thromboembolism. 

Low-Dose Xarelto More Effective Than Aspirin Preventing Blood Clots

Complications associated with left main bifurcation can impact stent choice.

Drug-Eluting Stents Effective for Percutaneous Coronary Intervention

A multi-faceted screening approach could prevent sudden cardiac deaths in young athletes.

Screening for Heart Defects May Prevent Juvenile Deaths

Including warning labels may improve healthy eating habits. 

Food Labeling Can Impact Healthy Eating

Americans admitted to the hospital for heart failure have a 6% higher risk of dying than patients admitted in the spring. 

ACC